Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL.
Hurtz C, Wertheim GB, Loftus JP, Blumenthal D, Lehman A, Li Y, Bagashev A, Manning B, Cummins KD, Burkhardt JK, Perl AE, Carroll M, Tasian SK
J Clin Invest. 2020 Jul 1;130(7):3637-3653. doi: 10.1172/JCI134424.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article